| Product Code: ETC11386927 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antibiotic Resistance Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antibiotic Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antibiotic Resistance Market - Industry Life Cycle |
3.4 Israel Antibiotic Resistance Market - Porter's Five Forces |
3.5 Israel Antibiotic Resistance Market Revenues & Volume Share, By Resistance Type, 2021 & 2031F |
3.6 Israel Antibiotic Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.7 Israel Antibiotic Resistance Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Israel Antibiotic Resistance Market Revenues & Volume Share, By Treatment Approach, 2021 & 2031F |
4 Israel Antibiotic Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in Israel |
4.2.2 Growing awareness about the implications of antibiotic resistance on public health |
4.2.3 Government initiatives to promote responsible antibiotic use and surveillance |
4.3 Market Restraints |
4.3.1 Limited availability of new antibiotics to combat resistant strains |
4.3.2 Lack of standardized guidelines for antibiotic prescribing and usage |
4.3.3 High costs associated with developing and implementing strategies to address antibiotic resistance |
5 Israel Antibiotic Resistance Market Trends |
6 Israel Antibiotic Resistance Market, By Types |
6.1 Israel Antibiotic Resistance Market, By Resistance Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Antibiotic Resistance Market Revenues & Volume, By Resistance Type, 2021 - 2031F |
6.1.3 Israel Antibiotic Resistance Market Revenues & Volume, By MDR, 2021 - 2031F |
6.1.4 Israel Antibiotic Resistance Market Revenues & Volume, By XDR, 2021 - 2031F |
6.1.5 Israel Antibiotic Resistance Market Revenues & Volume, By PDR, 2021 - 2031F |
6.2 Israel Antibiotic Resistance Market, By Pathogen |
6.2.1 Overview and Analysis |
6.2.2 Israel Antibiotic Resistance Market Revenues & Volume, By Bacteria, 2021 - 2031F |
6.2.3 Israel Antibiotic Resistance Market Revenues & Volume, By Virus, 2021 - 2031F |
6.2.4 Israel Antibiotic Resistance Market Revenues & Volume, By Fungi, 2021 - 2031F |
6.3 Israel Antibiotic Resistance Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Israel Antibiotic Resistance Market Revenues & Volume, By Culture-based, 2021 - 2031F |
6.3.3 Israel Antibiotic Resistance Market Revenues & Volume, By PCR, 2021 - 2031F |
6.3.4 Israel Antibiotic Resistance Market Revenues & Volume, By Rapid Tests, 2021 - 2031F |
6.4 Israel Antibiotic Resistance Market, By Treatment Approach |
6.4.1 Overview and Analysis |
6.4.2 Israel Antibiotic Resistance Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.4.3 Israel Antibiotic Resistance Market Revenues & Volume, By Novel Antibiotics, 2021 - 2031F |
7 Israel Antibiotic Resistance Market Import-Export Trade Statistics |
7.1 Israel Antibiotic Resistance Market Export to Major Countries |
7.2 Israel Antibiotic Resistance Market Imports from Major Countries |
8 Israel Antibiotic Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities implementing antibiotic stewardship programs |
8.2 Number of reported cases of antibiotic-resistant infections in Israel |
8.3 Antibiotic consumption rates in different healthcare settings |
9 Israel Antibiotic Resistance Market - Opportunity Assessment |
9.1 Israel Antibiotic Resistance Market Opportunity Assessment, By Resistance Type, 2021 & 2031F |
9.2 Israel Antibiotic Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.3 Israel Antibiotic Resistance Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Israel Antibiotic Resistance Market Opportunity Assessment, By Treatment Approach, 2021 & 2031F |
10 Israel Antibiotic Resistance Market - Competitive Landscape |
10.1 Israel Antibiotic Resistance Market Revenue Share, By Companies, 2024 |
10.2 Israel Antibiotic Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here